Alga Ecklonia bicyclis, Tribulus terrestris, and glucosamine oligosaccharide improve erectile function, sexual quality of life, and ejaculation function in patients with moderate mild-moderate erectile dysfunction: A prospective, randomized, placebo-controlled, single-blinded study

BioMed Research International

Volumn 2014, Issue , 2014, Pages

  Sansalone, Salvatore ^a   Leonardi, Rosario ^b   Antonini, Gabriele ^c   Vitarelli, Antonio ^d   Vespasiani, Giuseppe ^a   Basic, Dragoslav ^e   Morgia, Giuseppe ^f   Cimino, Sebastiano ^f   Russo, Giorgio Ivan ^f  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b Centro Uro Andrologico   (Italy)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

^d POLICLINICO   (Italy)

^e Clinical Center Ni   (Serbia)

^f UNIVERSITY OF CATANIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP; CYCLIC GMP; GLUCOSAMINE; GLUCOSAMINE OLIGOSACCHARIDE; HERBACEOUS AGENT; NATURAL PRODUCT; NITRIC OXIDE SYNTHASE; PLACEBO; TESTOSTERONE; TRIBULUS TERRESTRIS EXTRACT; UNCLASSIFIED DRUG; OLIGOSACCHARIDE;

ADULT; ALGA; ARTICLE; COLOR ULTRASOUND FLOWMETRY; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFICACY; ECKLONIA; ECKLONIA BICYCLIS; ERECTILE DYSFUNCTION; HUMAN; INTERNATIONAL INDEX OF ERECTILE FUNCTION; LIBIDO; MAJOR CLINICAL STUDY; MALE; MALE SEXUAL DYSFUNCTION; MALE SEXUAL HEALTH QUESTIONNAIRE EJACULATION DISORDER; MIDDLE AGED; MULTICENTER STUDY; ORGASM; PEAK SYSTOLIC VELOCITY; PENIS ERECTION; PROSPECTIVE STUDY; QUALITY OF LIFE; QUALITY OF LIFE ASSESSMENT; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SEXUAL HEALTH; SEXUAL INTERCOURSE; SEXUAL QUALITY OF LIFE; SEXUAL QUALITY OF LIFE INSTRUMENT FOR MEN; SEXUAL SATISFACTION; SINGLE BLIND PROCEDURE; TESTOSTERONE BLOOD LEVEL; TREATMENT OUTCOME; TRIBULUS TERRESTRIS; AGED; CLINICAL TRIAL; CONVALESCENCE; DRUG EFFECTS; EJACULATION; PATHOPHYSIOLOGY; PHYTOTHERAPY; PROCEDURES; TRIBULUS;

ALGAE; ECKLONIA; TRIBULUS TERRESTRIS;

AGED; EJACULATION; ERECTILE DYSFUNCTION; GLUCOSAMINE; HUMANS; MALE; MIDDLE AGED; OLIGOSACCHARIDES; PENILE ERECTION; PHYTOTHERAPY; PROSPECTIVE STUDIES; RECOVERY OF FUNCTION; TRIBULUS;

EID: 84924070306     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2014/121396     Document Type: Article

References (28)

1. P. Montorsi, P. M. Ravagnani, S. Galli et al., "Association between Erectile Dysfunction and Coronary Artery Disease: matching the Right Target with the right test in the right patient," European Urology, vol. 50, no. 4, pp. 721-731, 2006.
2. J. I. Mäkinen, A. Perheentupa, O. T. Raitakari, M. Koskenvuo, P. Pöllänen, and I. Huhtaniemi, "Sexual symptoms in aging men indicate poor life satisfaction and increased health service consumption," Urology, vol. 70, no. 6, pp. 1194-1199, 2007.
3. G. Jackson, R. C. Rosen, R. A. Kloner, and J. B. Kostis, "The second Princeton consensus on sexual dysfunction and cardiac risk: new guidelines for sexual medicine," The Journal of Sexual Medicine, vol. 3, no. 1, pp. 28-36, 2006.
4. V. Favilla, S. Cimino, C. Salamone et al., "Risk factors of sexual dysfunction after transurethral resection of the prostate (TURP): a 12 months follow-up," Journal of Endocrinological Investigation, vol. 36, pp. 1094-1098, 2013.
5. A. Salonia, G. Castagna, A. Saccà et al., "Is erectile dysfunction a reliable proxy of general male health status? The case for the international index of erectile function-erectile function domain,"The Journal of SexualMedicine, vol. 9, no. 10, pp. 2708-2715, 2012.
6. R. O. Rosen, W. A. Fisher, I. Eardley, C. Niederberger, A. Nadel, and M. Sand, "The multinational Men's Attitudes to Life Events and Sexuality (MALES) study: I. Prevalence of erectile dysfunction and related health concerns in the general population," CurrentMedical Research and Opinion, vol. 20, no. 5, pp. 607-617, 2004.
7. K.-K. Chew, J. Finn, B. Stuckey et al., "Erectile dysfunction as a predictor for subsequent atherosclerotic cardiovascular events: findings froma linked-data study," The Journal of Sexual Medicine, vol. 7, no. 1, pp. 192-202, 2010.
8. C. Vlachopoulos, K. Rokkas, N. Ioakeimidis, and C. Stefanadis, "Inflammation, metabolic syndrome, erectile dysfunction, and coronary artery disease: common links," European Urology, vol. 52, no. 6, pp. 1590-1600, 2007.
9. J.-Y. Dong, Y.-H. Zhang, and L.-Q. Qin, "Erectile dysfunction and risk of cardiovascular disease: meta-analysis of prospective cohort studies," Journal of the American College of Cardiology, vol. 58, no. 13, pp. 1378-1385, 2011.
10. B. P. Gupta, M. H. Murad, M. M. Clifton, L. Prokop, A. Nehra, and S. L. Kopecky, "The effect of lifestyle modification and cardiovascular risk factor reduction on erectile dysfunction: a systematic review and meta-analysis," Archives of Internal Medicine, vol. 171, no. 20, pp. 1797-1803, 2011.
11. G. I. Russo, S. Cimino, E. Fragala et al., "Insulin resistance is an independent predictor of severe lower urinary tract symptoms and of erectile dysfunction: results froma cross-sectional study," The Journal of Sexual Medicine, 2014.
12. R. C. Ma, W. So, X. Yang et al., "Erectile dysfunction predicts coronary heart disease in type 2 diabetes," Journal of the American College of Cardiology, vol. 51, no. 21, pp. 2045-2050, 2008.
13. K. Hatzimouratidis, E. Amar, I. Eardley et al., "Guidelines on male sexual dysfunction: erectile dysfunction and premature ejaculation," European Urology, vol. 57, no. 5, pp. 804-814, 2010.
14. A. Tsertsvadze, F. Yazdi, H. A. Fink et al., "Oral sildenafil citrate (viagra) for erectile dysfunction: a systematic review and metaanalysis of harms," Urology, vol. 74, no. 4, pp. 831.e8-836.e8, 2009.
15. P. Dorsey, C. Keel, M. Klavens, and W. J. G. Hellstrom, "Phosphodiesterase type 5 (PDE5) inhibitors for the treatment of erectile dysfunction," Expert Opinion on Pharmacotherapy, vol. 11, no. 7, pp. 1109-1122, 2010.
16. F. Iacono, D. Prezioso, E. Illiano, G. Romeo, A. Ruffo, and B. Amato, "Sexual asthenia: Tradamixina versus Tadalafil 5mg daily," BMC Surgery, vol. 12, supplement 1, article S23, 2012.
17. V. Favilla, G. I. Russo, S. Privitera et al., "Combination of intralesional verapamil and oral antioxidants for Peyronie's disease: a prospective, randomised controlled study," Andrologia, 2013.
18. G.Morgia, S.Cimino,V. Favilla et al., "Effects of Serenoa repens, selenium and lycopene (Profluss) on chronic inflammation associated with benign prostatic hyperplasia: results of "FLOG" (Flogosis and Profluss in Prostatic and Genital Disease), a multicentre Italian study," International Brazilian Journal of Urology, vol. 39, no. 2, pp. 214-221, 2013.
19. M. K. Cathcart, "Regulation of superoxide anion production by NADPH oxidase in monocytes/macrophages: contributions to atherosclerosis," Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 24, no. 1, pp. 23-28, 2004.
20. K. K. Griendling, D. Sorescu, andM. Ushio-Fukai, "NAD(P)H oxidase: role in cardiovascular biology and disease," Circulation Research, vol. 86, no. 5, pp. 494-501, 2000.
21. E. Vicari, S. la Vignera, R. Condorelli, and A. E. Calogero, "Endothelial antioxidant administration ameliorates the erectile response to PDE5 regardless of the extension of the atherosclerotic process," Journal of Sexual Medicine, vol. 7, no. 3, pp. 1247-1253, 2010.
22. P. Li, R. Dietz, and R. Von Harsdorf, "Differential effect of hydrogen peroxide and superoxide anion on apoptosis and proliferation of vascular smooth muscle cells," Circulation, vol. 96, no. 10, pp. 3602-3609, 1997.
23. L. Minutoli, A. Bitto, F. Squadrito et al., "Serenoa repens, lycopene and selenium: a triple therapeutic approach to manage benign prostatic hyperplasia," CurrentMedicinal Chemistry, vol. 20, no. 10, pp. 1306-1312, 2013. BioMed Research International 7
24. L. Vanella, G. I. Russo, S. Cimino, E. Fragala, V. Favilla, and G. li Volti, "Correlation between lipid profile and heme oxygenase system in patients with benign prostatic hyperplasia," Urology, vol. 83, no. 6, pp. 1444.e7-1444.e13, 2014.
25. S. la Vignera, R. Condorelli, E. Vicari, R. D'agata, and A. E. Calogero, "Endothelial antioxidant compound prolonged the endothelial antiapoptotic effects registered after tadalafil treatment in patients with arterial erectile dysfunction," Journal of Andrology, vol. 33, no. 2, pp. 170-175, 2012.
26. S. C. Kam, J.M. Do, J. H. Choi, B. T. Jeon, G. S. Roh, and J. S. Hyun, "In vivo and in vitro animal investigation of the effect of a mixture of herbal extracts fromTribulus terrestris and Cornus officinalis on penile erection," Journal of Sexual Medicine, vol. 9, no. 10, pp. 2544-2551, 2012.
27. E.Chung, H. Yan, L. de Young, andG. B. Brock, "PenileDoppler sonographic and clinical characteristics in Peyronie's disease and/or erectile dysfunction: an analysis of 1500 men with male sexual dysfunction," BJU International, vol. 110, no. 8, pp. 1201-1205, 2012.
28. O. Kayigil, E. Okulu, M. Aldemir, and E. Onen, "Penile revascularization in vasculogenic erectile dysfunction (ED): long-term follow-up," BJU International, vol. 109, no. 1, pp. 109-115, 2012.